WRB Stock Analysis: W. R. Berkley | NYSE
Insurance - Property & Casualty | NYSE, USA | Market Cap: 26.402m USD | 12M Return: 3.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 138M
EPS Trend: 95.3%
Qual. Beats: 1
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
W. R. Berkley Corporation (NYSE: WRB) is a U.S.-based insurance holding company that operates as a commercial line writer on a worldwide basis, distributing coverage through two segments: Insurance and Reinsurance & Monoline Excess. Founded in 1967 and headquartered in Greenwich, Connecticut, the company has been publicly traded since 1984 and is classified within the Financials sector as a Property & Casualty Insurance issuer.
The Insurance segment is the more diversified of the two, writing business across admitted lines, excess and surplus (E&S) lines, and specialty personal lines. Coverage offerings span accident and health, casualty, environmental, fine arts and jewelry, inland marine, commercial general liability, umbrella, professional liability, directors and officers, commercial property, surety, cyber risk, crime and fidelity, medical professional, workers compensation, management liability, energy and marine, and products tailored to the technology, life sciences, and travel industries. The segment also manages alternative risk programs and writes into the Lloyds marketplace.
The Reinsurance & Monoline Excess segment provides treaty and facultative reinsurance solutions to other insurers, including property and casualty reinsurance and monoline excess products. Facultative offerings include automatic, semi-automatic, and individual risk assumed reinsurance, along with turnkey products covering cyber, employment practices liability, liquor liability, and violent events.
As a specialty-focused commercial lines writer, Berkleys emphasis on E&S and reinsurance positions it in higher-margin, non-standard risk segments of the property and casualty market, where pricing and underwriting discipline tend to be more closely tied to individual risk characteristics than to standard market cycles.
- Specialty commercial lines premium growth sustains underwriting margins
- Catastrophe losses pressure combined ratio amid volatile weather
- Higher interest rates boost investment income on fixed maturity portfolio
| Net Income: 1.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.12 > 1.0 |
| NWC/Revenue: 68.99% < 20% (prev 68.33%; Δ 0.66% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.52b > Net Income 1.88b |
| Net Debt (-26.1b) to EBITDA (2.36b): -11.06 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (394.8m) vs 12m ago -1.26% < -2% |
| Gross Margin: 26.14% > 18% (prev 22.45%; Δ 3.69% > 0.5%) |
| Asset Turnover: 34.66% > 50% (prev 33.69%; Δ 0.97% > 0%) |
| Interest Coverage Ratio: 19.01 > 6 (EBIT TTM 2.41b / Interest Expense TTM 126.9m) |
| A: 0.23 (Total Current Assets 37.1b - Total Current Liabilities 26.8b) / Total Assets 44.3b |
| B: 0.31 (Retained Earnings 13.8b / Total Assets 44.3b) |
| C: 0.06 (EBIT TTM 2.41b / Avg Total Assets 42.8b) |
| D: 0.28 (Book Value of Equity 9.74b / Total Liabilities 34.6b) |
| Altman-Z'' = 3.21 = A |
| DSRI: 0.91 (Receivables 7.28b/7.48b, Revenue 14.8b/13.9b) |
| GMI: 0.86 (GM 22.45% / 26.14%) |
| AQI: 0.97 (AQ_t 0.15 / AQ_t-1 0.16) |
| SGI: 1.07 (Revenue 14.8b / 13.9b) |
| TATA: -0.04 (NI 1.88b - CFO 3.52b) / TA 44.3b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 71.54 with a total of 1,476,171 shares traded. Over the past week, the price has changed by +0.75%, over one month by +8.14%, over three months by +8.26% and over the past year by +3.92%.
Current recommended Stop Loss: 67.50 (which is 5.6% or 2.7 ATR below the current price).
W. R. Berkley has received a consensus analysts rating of 3.56. Therefore, it is recommended to hold WRB.
- StrongBuy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 66.8 | -6.7% |
P/E Trailing = 15.0254
P/E Forward = 15.6006
P/S = 1.7778
P/B = 2.7551
P/EG = 4.2167
Revenue TTM = 14.8b USD
EBIT TTM = 2.41b USD
EBITDA TTM = 2.36b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 61.5m USD (from shortTermDebt, last fiscal year)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -26.1b USD (calculated: Debt 2.84b - CCE 28.9b)
Enterprise Value = 319.6m USD (26.4b + Debt 2.84b - CCE 28.9b)
Interest Coverage Ratio = 19.01 (Ebit TTM 2.41b / Interest Expense TTM 126.9m)
EV/FCF = 0.09x (Enterprise Value 319.6m / FCF TTM 3.37b)
FCF Yield = 1.05k% (FCF TTM 3.37b / Enterprise Value 319.6m)
FCF Margin = 22.70% (FCF TTM 3.37b / Revenue TTM 14.8b)
Net Margin = 12.64% (Net Income TTM 1.88b / Revenue TTM 14.8b)
Gross Margin = 26.14% ((Revenue TTM 14.8b - Cost of Revenue TTM 11.0b) / Revenue TTM)
Gross Margin QoQ = 47.51% (prev 20.58%)
Tobins Q-Ratio = 0.01 (Enterprise Value 319.6m / Total Assets 44.3b)
Interest Expense / Debt = 4.47% (Interest Expense 126.9m / Debt 2.84b)
Taxrate = 20.15% (475.0m / 2.36b)
NOPAT = 1.93b (EBIT 2.41b * (1 - 20.15%))
Current Ratio = 1.38 (Total Current Assets 37.1b / Total Current Liabilities 26.8b)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.74b)
Debt / EBITDA = -11.06 (Net Debt -26.1b / EBITDA 2.36b)
Debt / FCF = -7.74 (Net Debt -26.1b / FCF TTM 3.37b)
Total Stockholder Equity = 9.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.38% (Net Income 1.88b / Total Assets 44.3b)
RoE = 19.48% (Net Income TTM 1.88b / Total Stockholder Equity 9.63b)
RoCE = 19.33% (EBIT 2.41b / Capital Employed (Equity 9.63b + L.T.Debt 2.84b))
RoIC = 11.46% (NOPAT 1.93b / Invested Capital 16.8b)
WACC = 5.75% (E(26.4b)/V(29.2b) * Re(5.98%) + D(2.84b)/V(29.2b) * Rd(4.47%) * (1-Tc(0.20)))
Discount Rate = 5.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -1.29%
[DCF] Terminal Value 74.50% ; FCFF base≈3.47b ; Y1≈3.29b ; Y5≈3.11b
[DCF] Fair Price = 201.5 (EV 48.9b - Net Debt -26.1b = Equity 75.0b / Shares 372.3m; r=8.35% [WACC [floored]]; 5y FCF grow -6.60% → 2.50% )
EPS Correlation: 95.35 | EPS CAGR: 17.75% | SUE: 2.01 | # QB: 1
Revenue Correlation: 99.28 | Revenue CAGR: 10.02% | SUE: 0.53 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.09 | Chg30d=+0.07% | Revisions=+0% | Analysts=15
EPS next Quarter (2026-09-30): EPS=1.09 | Chg30d=-0.16% | Revisions=+17% | Analysts=16
EPS current Year (2026-12-31): EPS=4.67 | Chg30d=-0.16% | Revisions=+0% | GrowthEPS=+7.8% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=4.80 | Chg30d=-0.50% | Revisions=-12% | GrowthEPS=+2.9% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +0% (up=7, down=7)